Anixa Biosciences’ (ANIX) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They currently have a $10.00 price target on the stock. Other equities research analysts also recently issued reports about the company. HC Wainwright reiterated a “buy” rating and issued […]
D. Boral Capital reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They currently have a $10.00 price target on the stock. Other equities research analysts also recently issued reports about the company. HC Wainwright reiterated a “buy” rating and issued […]
